These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27218435)

  • 21. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
    Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin).
    Kako S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kanda Y
    Hematology; 2017 Apr; 22(3):129-135. PubMed ID: 27905258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
    Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of 34 patients with cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation].
    Li S; Shen ZH; Wan LP; Bao AH; Yang J; Tong Y; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):843-847. PubMed ID: 33190442
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of allogeneic hematopoietic stem cell transplantation in treatment of childhood myelogenous leukemia: the observation of 24 cases].
    Sun Y; Sun RJ; Wei ZJ; Xiao J; Zhang YC; Gao YQ; Zhu HL
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):813-6. PubMed ID: 23302609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
    Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.
    Riddell P; Vasudevan-Nampoothiri R; Ma J; Singer LG; Lipton JH; Juvet SC
    Respir Res; 2021 Apr; 22(1):101. PubMed ID: 33827576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 years.
    Hierlmeier S; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
    PLoS One; 2018; 13(10):e0204914. PubMed ID: 30325953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Chen YB; Shah NN; Renteria AS; Cutler C; Jansson J; Akbari M; Chen C; Quadri S; Parfionovas A; Devine SM
    Blood Adv; 2019 Dec; 3(23):4136-4146. PubMed ID: 31821456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.
    Kawa K; Sawada A; Sato M; Okamura T; Sakata N; Kondo O; Kimoto T; Yamada K; Tokimasa S; Yasui M; Inoue M
    Bone Marrow Transplant; 2011 Jan; 46(1):77-83. PubMed ID: 20498651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 35. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
    Mo X; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X
    Front Med; 2019 Jun; 13(3):354-364. PubMed ID: 30680605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
    Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation.
    Tong K; Meng Y; Zhang L; Lei X; Liu Q; Guan X; Yu J; Dou Y
    Ann Hematol; 2024 Jul; 103(7):2485-2497. PubMed ID: 38709259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
    Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
    Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.